- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05516849
Placebo Versus Oxandrolone Supplementation in Trauma
Placebo Versus Oxandrolone Supplementation in Trauma: A Randomized Multi-Center Double Blind Clinical Trial in High-Energy Lower Extremity Trauma (POST-Injury Trial)
Study Overview
Detailed Description
Lower extremity fractures associated with high-energy mechanisms of injury (combat injuries including blast or crush injuries, motor vehicle accidents, fall from significant height, gunshot injuries) are unfortunately common among active service members and civilians presenting to level-1 trauma centers worldwide. High-energy fractures have several unique characteristics that distinguish them from low-energy injuries. They typically occur in predominately younger, male patients (30-65 years old)1 and involve significant soft-tissue stripping or damage. These patients require at least one major reconstructive surgery, with the majority requiring multiple reconstructive surgeries, each associated with additional soft tissue injury and subsequent prolonged immobilization to facilitate limb stabilization. Despite extended rehabilitation focused on neuromuscular retraining and muscular development, the result is often permanent limitations of ambulation and medical retirement from active duty due to volumetric muscle loss. So, while advances in orthopedic approaches to fracture care have lowered complications such as non-union and malunion, rendering them less significant as limitations to restoring function soft-tissue complications now predominate.
Oxandrolone has been successfully utilized to accelerate muscular recovery, reduce muscle loss, and improve function in several populations including healthy elderly patients with frailty/sarcopenia, patients with large surface area burns, neuromuscular diseases, HIV, congenital heart disease and genetic diseases including Klinefelter's and Turner's Syndromes. In addition, Oxandrolone has also been safely used in pediatric patients to treat constitutionally delayed growth. Given the similarities in patient populations and the known limitations of volumetric muscle loss in military personnel and civilians after major trauma, Oxandrolone supplementation may reduce initial volumetric muscle loss and improve long-term muscle mass and function.
Study Type
Phase
- Phase 3
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male
- Ages 18-55 [inclusive]
- Skeletally-mature as based upon tibial or femoral physeal closure41
- Fracture of the femur or tibia treated with open reduction and internal fixation (simple articular patterns allowed).
- High energy injuries with associated local soft tissue damage. -
Exclusion Criteria:
- Unable to participate in rehabilitation including severe head injury, pre-existing TBI or cognitive dysfunction (stroke, dementia, documented developmental delay), patients with significant spinal cord injury or pre-accident paralytic injury or condition will beessential treatment in both intervention and control groups.
- Medically unfit for anabolic steroid treatment including those with active malignancy, concurrent prednisone use, elevated liver enzymes at baseline (baseline bloodwork to include LFT)
- Fracture due to primary or metastatic bone lesion
- Any contraindications to MRI.
- Patients with major psychiatric illness [trauma presentation for suicide attempts] and incarcerated patients will be excluded as they may lack autonomy, decision-making capacity and the ability to meet follow-ups.
- Patients with substance use disorders, due to increased abuse potential and possible baseline hepatic injury.
- Patients who are on blood thinning medication, at baseline.
- Patients receiving hormone treatment.
- Patients with active cancers.
Patients with a history of hypercalcemia/parathyroid disease and chronic renal disease.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Oxandrolone
Participants will be randomly assigned in a 1:1 fashion to one of the two treatment arms using the REDCap database randomization procedure.
|
Oxandrolone is a synthetic anabolic androgenic steroid that induces its responses by binding to androgen receptors which modulates gene expression to increase protein synthesis and efficient utilisation of amino acids.
Oxandrolone was first synthesized in 1962 through 17alpha-alkylation of testosterone resulting in a formal composition of (4bS,7S,9aS,9bR,11aS)-tetradecahydro-7-hydroxy-4aS,6aS,7-trimethyl- cyclopentanaphthopyran-2(1H)-one and molecular formula of C19H30O3.
|
Placebo Comparator: Placebo
Participants will be randomly assigned in a 1:1 fashion to one of the two treatment arms using the REDCap database randomization procedure.
|
As there is currently no approved medication to aid in soft-tissue regeneration, we will be using a placebo control.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Delta volumetric vastus medialis diameter on MRI
Time Frame: upto 6 months
|
MRI is taken to assess the vastus medialis muscle mass.
|
upto 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Delta volumetric thigh muscle mass on MRI
Time Frame: Up to 1 year
|
Delta volumetric thigh muscle mass on MRI at 52 week Post treatment and the VMO (Vastus Medialis) at 26 week visit.
|
Up to 1 year
|
Functional measure: 6-minute walk test
Time Frame: Up to 1 year
|
Up to 1 year
|
|
Activity count by ActiGraph GT3X-BT
Time Frame: Up to 1 year
|
The actigraph measures sleep efficiency.
|
Up to 1 year
|
Short Form 36 Health Survey
Time Frame: Up to 1 year
|
The minimum score is 0, and maximum score is 5.
|
Up to 1 year
|
Patient-Reported Outcomes Measurement Information System (PROMIS)
Time Frame: Up to 1 year
|
The minimum score is 0, and maximum score is 10.
|
Up to 1 year
|
Standard AP and Lateral X-Rays
Time Frame: Through study completion, an average of 1 year
|
Time to radiographic union of fracture in weeks based on bridging callous of 3 of 4 cortices on standard AP and lateral x-rays
|
Through study completion, an average of 1 year
|
Length of in-patient Acute Hospital stay, and Rehabilitation stay
Time Frame: Through study completion, an average of 1 year
|
Length of in-patient Acute Hospital stay, and Rehabilitation stay to be determined by the orthopedic surgeon.
|
Through study completion, an average of 1 year
|
MARX Scale
Time Frame: Up to 1 year
|
The minimum score is 0, and maximum score is 10.
|
Up to 1 year
|
VAS Score
Time Frame: Up to 1 year
|
The minimum score is 0, and maximum score is 10.
|
Up to 1 year
|
Hand-Held Dynamometer
Time Frame: Up to 1 year
|
The hand-held dynamometer is a small device that fits in the examiner's hand and is placed at precise locations on a subject's limb in an effort to assess the force generated by various muscles or groups of muscles.The minimum score is 0, and maximum score is 10.
|
Up to 1 year
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3822: POST-INJURY
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trauma Injury
-
Second Affiliated Hospital, School of Medicine,...Not yet recruiting
-
Chi-Ming HuangUMKC School of MedicineNot yet recruitingConcussion | Head Injury Trauma
-
Advocate Health CareRosalind Franklin University of Medicine and ScienceCompletedTrauma | Blunt Trauma | Blunt Injury | Accident | Multiorgan InjuryUnited States
-
Assiut UniversityNot yet recruitingChest Injury Trauma
-
Wake Forest University Health SciencesMind and Life Institute, Hadley, MassachusettsCompleted
-
Australian and New Zealand Intensive Care Research...Monash University; University College Dublin; Health Research Board, Ireland; Health... and other collaboratorsRecruitingWounds and Injuries | Trauma | Traumatic Brain Injury | Multiple Trauma | Major Trauma | Traumatic Injury | Penetrating Injury | Blunt InjuryAustralia, Ireland, Finland, New Zealand, Slovenia, Germany, Saudi Arabia, Switzerland
-
Assiut UniversityUnknown
-
University of PittsburghCompletedHead Injury, MinorUnited States
-
Groupe Hospitalier Paris Saint JosephCompleted
Clinical Trials on Oxandrolone
-
Thomas Jefferson UniversityNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
National Institute of Neurological Disorders and...Jefferson Medical College of Thomas Jefferson UniversityCompletedTurner's SyndromeUnited States
-
CJ CheilJedangNot yet recruitingPharmacokinetics
-
National Institute of Diabetes and Digestive and...Completed
-
Denver Health and Hospital AuthorityWithdrawnAnemia | Trauma | Functional Iron DeficiencyUnited States
-
US Department of Veterans AffairsCompletedSpinal Cord InjuryUnited States
-
University of Southern CaliforniaActive, not recruiting
-
University of UtahCompleted
-
US Department of Veterans AffairsTerminated
-
Par Pharmaceutical, Inc.Cetero Research, San AntonioCompletedTo Determine the Bioequivalence Under Fasting ConditionsUnited States